Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: Modulation by cytokines

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7140-7147

  Arnold, Ralf ^a,b   Seifert, Martina ^a   Asadullah, Khusru ^a   Volk, Hans Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIGAND; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; SKIN INFLAMMATION; T LYMPHOCYTE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; EPIDERMIS; FAS LIGAND PROTEIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-15; JURKAT CELLS; KERATINOCYTES; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; RECEPTOR CROSS-TALK; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0033564708     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Nickoloff, B. J., and L. A. Turka. 1994. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol. Today 15:464.
2. Arnold, R., and W. König. 1996. ICAM-1 expression and low-molecular-weight G-protein activation of human bronchial epithelial cells (A549) infected with RSV. J. Leukocyte Biol. 60:766.
3. Zepter, K., A. Häffner, L. F. Soohoo, D. De Luca, H.-P. Tang, P. Fisher, J. Chavinson, and C. Elmets. 1997. Induction of biologically active IL-1β-converting enzyme and mature IL-1β in human keratinocytes by inflammatory and immunologic stimuli. J. Immunol. 159:6203.
4. Stoll, S., G. Müller, M. Kurimoto, J. Saloga, T. Tanimoto, H. Yamauchi, H. Okamura, J. Knop, and A. H. Enk. 1997. Production of IL-18 (IFN-γ-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159:298.
5. Arnold, R., B. Humbert, H. Werchau, H. Gallati, and W. König. 1994. Interleukin-8, interleukin-6, and soluble tumor necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82:126.
6. Fuchs, E., 1990. Epidermal differentiation: the bare essentials. J. Cell Biol. 111: 2807.
7. Lin, T. S., T. Brunner, B. Tietz, J. Madsen, E. Bonfoco, M. Reaves, M. Huflejt, and D. R. Green. 1998. Fas ligand mediated killing by intestinal intraepithelial lymphocytes: participation in intestinal graft-versus-host disease. J. Clin. Invest 101:570.
8. Nakajima, M., A. Nakajima, N. Kayagaki, M. Honda, H. Yagita, and K. Okumura. 1997. Expression of Fas Ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin. Immunol. Immunopathol. 83:223.
9. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317.
10. Leverkus, M., M. Yaar, and B. A. Gilchrest. 1997. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp. Cell Res. 232:255.
11. Nagata, S., 1996. Fas and Fas ligand: a death factor and its receptor. Adv. Immunol. 57:129.
12. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
13. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873.
14. Castro, J. E., J. A. Listman, B. A. Jacobson, Y. Wang, P. A. Lopez, S. Ju, P. W. Finn, and D. L. Perkins. 1996. Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5:617.
15. + T cells. Nature 376:181.
16. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytotoxic T-cell cytotoxicity is mediated through perforin and Fas lytic pathway. Nature 370:650.
17. Johnson, R. P., 1997. Upregulation of Fas Ligand by simian immunodeficiency virus: a nefarious mechanism of immune evasion. J. Exp. Med. 186:1.
18. Hahne, M., D. Rimoldi, M. Schröler, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, et al. 1996. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363.
19. Fergusson, T. A., and T. S. Griffith. 1997. A vision of cell death: insights into immune privilege. Immunol. Rev. 156:167.
20. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations Immunol. Today 16:39.
21. Sayama, K., S. Yonehara, Y. Watanabe, and Y. Miki. 1994. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:330.
22. Matsue, H., H. Kobayashi, T. Hosokawa, T. Akitaya, and A. Ohkawara. 1995. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN-γ-treated cultured keratinocytes. Arch. Dermatol. Res. 287:315.
23. Gutierrez-Steil, C., T. Wrone-Smith, X. Sun, J. G. Krueger, T. Coven, and B. J. Nickoloff. 1998. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J. Clin. Invest. 101:33.
24. Berthou, C., L. Michel, A. Soulie, F. Jean-Louis, B. Flageul, L. Dubertret, F. Sigaux, Y. Zhang, and M. Sasportes. 1997. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense J. Immunol. 159:5293.
25. Köck, A., T. Schwarz, R. Kimbauer, A. Urbanski, P. Perry, J. C. Ansel, and T. A. Luger. 1990. Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172:1609.
26. DeVos, S., M. Brach, A. Budnik, M. Grewe, F. Herrmann, and J. Krutmann. 1994. Posttranscriptional regulation of interleukin-6 gene expression in human keratinocytes by ultraviolet B radiation. J. Invest. Dermatol. 103:92.
27. Grewe, M., K. Gyufu, and J. Krutmann. 1995. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation J. Invest. Dermatol. 104:3.
28. Boukamp, P., R. T. Petrussevska, D. Breitkreuz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761.
29. Lieber, M., B. Smith, A. Szakal, W. Nelson-Rees, and G. Todaro. 1976. A continuous-tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells Int. J. Cancer 17:62.
30. Koopman, G., C. P. M. Reutelingsperger, G. A. M. Kuijten, R. M. J. Keehnen, S. T. Pals, and M. H. J. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415.
31. Bradford, M. M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
32. Laemmli, U. K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
33. van Parijs, L., and A. Abbas. 1996. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8:355.
34. Walker, P. R., P. Saas, and P.-Y. Dietrich. 1997. Role of Fas Ligand (CD95L) in immune escape: the tumor cell strikes back. J. Immunol. 158:4521.
35. Yamagami, S., H. Kawashima, T. Tsuru, H. Yamagami, N. Kayagaki, H. Yagita, K. Okumura, and D. S. Gregerson. 1997. Role of Fas-Fas ligand interactions in the immunoreaction of allogeneic mouse comeal transplants. Transplantation 64:1107.
36. Xerri, L., E. Devilard, J. Hassoun, C. Mawas, and F. Birg. 1997. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. Mol. Pathol. 50:87.
37. Luger, T. A., and T. Schwarz. 1993. Epidermal Growth Factors and Cytokines. Marcel Dekker, New York.
38. Guy-Grand, D., J. P. DiSanto, P. Henchoz., M. Malassis-Séris, and P. Vassalli. 1998. Small bowel enteropathy: role of intraepithel lymphocytes and of cytokines (IL-12, IFN-γ, TNF) in the induction of epithelial cell death and renewal. Eur. J. Immunol. 28:730.
39. Kiener, P. A., P. M. Davis, G. C. Starling, C. Mehlin, S. J. Klebanoff, J. A. Ledbetter, and W. C. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages J. Exp. Med. 185:1511.
40. Strasser, A., and L. O'Connor. 1998. Fas ligand-caught between Scylla and Charybdis. Nat. Med. 4:21.
41. Wen, L. P., K. Madani, J. A. Fahrni, S. R. Duncan, and G. D. Rosen. 1997. Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. Am. J. Physiol. 273:L921.
42. Nakashima, T., H. Sasaki, M. Tsuboi, A. Kawakami, K. Fujiyama, T. Kiriyama, K. Eguchi, M. Ichikawa, and S. Nagataki. 1998. Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells. Endocrinology 139:2032.
43. Schneider, P., N. Holler, J.-L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205.
44. Suda, T., H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing J. Exp. Med. 186:2045.
45. Tanaka, M., T. Itai, M. Adachi, and S. Nagata. 1998. Downregulation of Fas ligand by shedding. Nat. Med. 4:31.
46. Duslin, M. L., K. H. Singer, D. T. Tuck, and T. A. Springer. 1988. Adhesion of T lymphocytes to epidermal keratinocytes is regulated by interferon γ and is mediated by intercellular adhesion molecule-1 (ICAM-1). J. Exp. Med 167:1323.
47. Korbutt, G. S., J. F. Elliott, and R. V. Rajotte. 1997. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46:317.
48. Lau, H. T., M. Yu, A. Fontana, and C. J. Stoecken, Jr. 1996. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109.
49. Bécherel, P.-A., L. Legoff, C. Francès, O. Chosidow, J.-J. Guillosson, P. Debré, M. D. Mossalayi, and M. Arock. 1997. Cutting edge: induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3′,5′-monophosphate-dependent mechanism. J. Immunol. 159:5761.
50. Borkowski, T. A., J. J. Letterio, A. G. Farr, and M. C. Udey. 1996. A role for endogenous transforming growth factor β1 in Langerhans cell biology: the skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184:2417.
51. H2 responses, Immunol. Today 12:49.
52. De Waal Malefyt, R., J. Abrams, B. Benett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J. Exp. Med. 174:1209.
53. Merly, F., C. Huard, I. Asselin, P. D. Robbins, and J. P. Tremblay. 1998. Anti-inflammatory effect of transforming growth factor-β1 in myoblast transplantation. Transplantation 65:793.
54. Asadullah, K., W. Sterry, K. Stephanek, D. Jasulaitis, M. Leupold, H. Audring, H. D. Volk, and W. D. Döcke. 1998. IL-10 is a key cytokine in psoriasis: proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 101:783.
55. Genestier, L., S. Kasibhatla, T. Brunner, and D. R. Green. 1999. Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-myc. J. Exp. Med. 189:231.
56. Allison, J., H. M. Georgiou, A. Strasser, and D. L. Vaux. 1997. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA 94:3943.
57. Kang, S.-M., D. B. Schneider, Z. Lin, D. Hanahan, D. A. Dichek, P. G. Stock, and S. Baekeskov. 1997. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:738.